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ABSTRACT 
The long term goal of the research effort in our group was to develop a new rapid 
diagnostic process for sepsis. The specific project described in this work aims to   
obtain these “pure” isolates of the infectious bacteria within a total time of less than 1.5 
hours. The proposed isolation process consists of 2 steps: (a) a novel kinetically limited 
density differential centrifugation step that serves as a “coarse” method, and (b): a 
dielectrophoresis (DEP) based sorting technique that serves as a “polishing” step. 
Kinetically Limited Density Differential Centrifugation enables us to convert a 
mixture in which the bacteria are an extremely small fraction of the particles to a 
suspension where bacteria constitute the majority of the particles. It is expected that 
the sample yielded by this separation technique can be “polished” using flow through 
dielectrophoresis (DEP). We also measured the DEP properties of target bacteria and 
RBC to determine the experiment condition for further purification. Besides that, we 
designed and fabricated the MEMS device for Flow-Through Dielectrophoresis (DEP) to 
obtain pure isolates of bacteria. 
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CHAPTER 1 
INTRODUCTION  
1.1. Specific aims 
The long term goal of the research effort in our group was to develop a new diagnostic 
process that will aid in the management of sepsis by (a) detecting viable bacteria in 
blood samples (if present) within 2-12 hours with a sensitivity and specificity of >98% (b) 
isolating and identifying these bacteria within an additional 2 hours with an accuracy of > 
95%, and (c) establishing their antibiotic susceptibility profiles within 6 hours. Using 
current technology, it takes 1-5 days to detect the presence of viable bacteria in blood, 
approximately 1 day to identify the bacteria, and an additional 2-5 days to obtain the 
antibiotic susceptibility profile.  
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Figure 1.1 Outline of proposed diagnostic process 
 
In this specific project, we attempted to realize the steps A1 and A2 of the figure above. 
These steps enabled us to obtain “pure” isolates of the infectious bacteria within a total 
time of less than 1.5 hours. Once “pure” isolates were obtained, the identity of the 
bacteria can then be obtained using Surface Enhanced Raman Spectroscopy (SERS) in 
less than 20 minutes.  The proposed isolation process consists of 2 steps: (a) a novel 
Kinetically Limited Density Differential Centrifugation step that serves as a “coarse” 
method, and (b): a dielectrophoresis (DEP) based sorting technique that serves as a 
“polishing” step. 
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The proposed specific aims are: 
1. To use Kinetically Limited Density Deference Centrifugation to isolate bacteria from (a) 
positive blood culture samples; (b) from whole blood. For current blood culture systems, 
at the time the culture turns “positive”, there are about 106 – 107 bacteria present in the 
growth suspension. The growth suspension consists of blood diluted in a 1:5 to 1:10 
ratio into a microbiological growth medium containing proteins, salts, sugars etc. (Blood 
itself is a complex matrix consisting of ~109 red blood cells (RBC), ~107 white blood cells 
(WBC), ~108 platelets and plasma). Using the more advanced method being developed in 
our group, the samples can be flagged positive as soon as the bacteria concentration has 
risen to ~ 1000 CFU/ml. We will thus examine the feasibility of our system to obtain a 
relatively pure sample of bacteria from samples where the bacteria concentration lies 
within these two limits   
2. Measure the DEP properties of target bacteria and RBC to determine the experiment 
condition for further purification.  
3. Design and fabricate the MEMS device for Flow Through Dielectrophoresis (DEP) to 
obtain pure isolates of bacteria. 
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1.2. Background and significance  
1.2.1. Epidemiology of sepsis 
Sepsis is a disease which is an inflammatory response to microbes in blood, lungs, or 
other tissues that are sterile under normal circumstances. Sepsis can originate anywhere 
bacteria enters the human body, but since almost all tissues are washed by blood, this 
usually also leads to blood infection (septicemia). During infection, bacteria can produce 
and release complex molecules, which can provoke a dramatic response by the immune 
system. It can lead to septic shock, multiple organ dysfunction syndrome and death. 
Most of the sepsis cases are caused by E coli, P. aeruginosa, Klebsiella etc. It has been 
estimated (Angus and others 2001) that each year in the US, over 751,000 cases of 
severe sepsis occurs, out of which 383,000 (51.1%) require intensive care, and 215,000 
(28.6%) are fatal. Other estimates (Wenzel and Edmond 2001) are lower (about 105,000 
deaths each year). To put the numbers in perspective: even assuming that the lower 
estimate is correct, about 3 times as many people die from sepsis than from breast 
cancer. 
 
Current technologies to detect such few bacteria in blood generally take 2 to 5 days to 
get the results. Unfortunately, patients who suffer sepsis may turn to organ dysfunction 
and low blood pressure during that time. In the past 3 decades, the ~30% mortality rate 
of sepsis has remained essentially unchanged. Numerous studies (Doern and others 
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1994; Kang and others 2003)  have pointed out that the quicker one can detect the 
presence of bacteria in the blood, and identify the best antibiotic to be used, with the 
more successful one being able to reduce mortality. 
 
1.2.2. Current clinical diagnostic protocol and technology  
When a patient exhibits symptoms suggesting sepsis, clinicians call for a blood culture to 
check the presence of pathogens in the patient’s blood. Blood is drawn from the patient, 
inoculated into a bottle containing growth medium, and the suspension (blood + growth 
medium) is incubated. Automated Blood Culture Systems (such as the BACTECTM, 
BacT/AlertTM and VitekTM) are used to monitor the bottle round-the-clock. These systems 
look for changes to the composition of the suspension (O2 / CO2 levels, pH etc.) brought 
about by bacterial metabolism. 
 
If changes are detected, the bottle in question is flagged as positive. For many of the 
commonly occurring bacteria such as E coli, Pseudomonos, Group B Streptococci, etc., it 
usually takes 12-24 hours for bottles to turn positive. If the initial load of bacteria in the 
blood drawn is low (< 10 CFU/ml), it may take longer (even up to 72 hours). Though the 
practice is to keep the culture running for 120 hours (5 days) before deeming it to be 
negative, if the culture remains negative after 72 hours (3 days), it is unlikely to turn 
positive over the next couple of days.  
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If a positive result is obtained from the blood culture, the clinician typically orders the 
administration of broad-spectrum antibiotics. Once information on the identity of the 
infectious agent (bacteria) is available, more effective antibiotics can be administered. 
Currently, semi automated Microbial Identification Systems (MIS) exist (such as the 
BiologTM ) that can run a large number of reactions in micro-titer wells, and depending 
on the levels of growth observed in each of them, predict the identity of the infective 
bacteria (based on information stored in its database). Typically, these systems require 
that the bacteria isolated from the blood culture to be grown on their specially designed 
nutrient agar for 18-24 hours, isolated from colonies suspended at particular densities in 
specially formulated buffers, and then loaded into their titer wells (where they are 
incubated for 4 -24 hours). Thus, an additional 1-2 days typically elapse before the 
clinician can get information regarding the identity of the bacteria. 
 
1.2.3. Other technologies in development for detecting and identifying 
There are a number of other efforts to develop improved culture-based technologies. 
Most of these technologies aim to develop more sensitive O2, CO2, pH or thermal 
sensors (Sengupta and others 2009). However, as we explain later (in Section 2.1.1), the 
long Times to Positivity (TTPs) that are observed for the BACTECTM, BacT/AlertTM etc 
when initial bacterial loads are low, arise from fundamental limitations in the bacterial 
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metabolism rate. Yang and co-workers (Yang and others 2005) have tried to cut down 
TTPs by pre-concentrating the bacteria using dielectrophoresis (DEP) prior to culture. 
But because their method requires the suspension handled to pass through 
micro-channels only 10 micron deep, and the electric field needed for corralling the 
bacteria selectively from other particles is partially disrupted if there are too many other 
particles present, their method is applicable only to suspensions with “low” volume 
fractions of dispersed solids (largely clear suspensions such as water, growth media, or 
apple juice). In addition, there are other drawbacks, including potential inactivation of 
bacteria in high strength electric fields and less than stellar capture efficiencies that may 
lead to false negatives. 
 
Over the last decade, considerable effort has been directed towards developing DNA 
based, and other molecular, non-culture based methods for the diagnosis of Sepsis. 
These were recently reviewed by Mancini. (Mancini and others 2010) As reported, 
Polymerase Chain Reaction (PCR) based methods (including Real Time PCR) suffer from 
four major drawbacks: (a) human DNA / RNA, which is present at much higher levels 
relative to bacterial DNA in blood samples, interferes with the extraction and 
amplification of the latter. Thus, the number of bacteria (amount of bacterial DNA) that 
needs to be present for these techniques to be able to detect them (the detection limit) 
is fairly high (> 104 CFU/ml); (b) presence of PCR inhibitors in the blood sample, leading 
to false negatives; (c) presence of contaminant bacterial DNA in reagents used, leading 
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to false positives (sterilization of reagents kills any bacteria present, but does not always 
eliminate DNA present); and (d) the risk of carryover contamination among samples in 
the same extraction round. 
 
A significant amount of research has been devoted to overcoming these obstacles, with 
varying degrees of success. The use of ultra-pure chemicals and high-quality packaging in 
single-use doses can limit the extent of contamination of chemicals by bacterial DNA. 
Also, proteinases included among the reagents can degrade some of the PCR inhibitors 
present, and the use of automated systems with single use conduits and reactors can 
reduce carryover contamination to an extent. Finally, the amount of human DNA can be 
reduced prior to analysis either by selective digestion by enzymes, or by physical 
methods like affinity chromatography. Using combinations of the above, it is now quite 
readily feasible to use RT-PCR to identify bacteria in blood culture bottles that have been 
flagged positive. (Typically, by the time the culture bottles have been flagged positive, 
the concentration of bacteria there has risen to > 106 CFU/ml.) There are in fact, a 
number of technologies already on the market that do so – such as the PNA-FSH 
(AdvanDX, Woburn, MA), Hyplex BloodScreen (BAG, Germany), “Prove it Sepsis” 
(Mobidiag, Finland) etc, and their turnaround time is approximately 3 hours. There has 
also been some success in trying to detect the bacteria directly from blood, with three 
technologies having recently obtained licenses in Europe. The first, called Septi-Test 
(Molzym, Bremen, Germany) is a broad-range PCR-based assay targeting the 16S rRNA 
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genes of bacteria. It has a few major drawbacks: a detection limit of 20-40 CFU/ml (in 
many cases, the bacterial load in the blood may be as low as ~ 1 CFU/ml), a relatively 
long turn-around time of 8-12 hours (that is not that much faster than culture), and 
being prone to provide large number of false positives due to the influence of 
contaminating DNA. The second, called Vyoo (SIRS-Lab, Jena, Germany) is a multiplex 
PCR-based assay addressing approximately 35 bacterial species, and certain genes that 
confer antibiotic resistance such as mecA, vanA, vanB and vanC. Like the Septi-test, 
however, it is also reportedly prone to giving false positives due to contamination, but 
has a lower detection limit (3-10 CFU/ml as claimed by the company), and a shorter 
turnaround time (~8 hours). The most promising system of this type is the Septi-Fast 
system from Roche Diagnostics, which claims to offer results as quickly as 6 hours (but 
may take longer, depending on the sample). By using a disposable cassette with 
integrated reagent reservoirs, mechanisms for dispensing reagents and performing 
RT-PCR, it greatly reduces the false positives that plague the other two. Its major 
drawback is that it is able to detect just 25 common pathogens, and the detection limit 
varies from 3 - 30 CFU/ml, depending on the pathogen (that may, in many cases, be 
insufficient to detect pathogens). Also, the special manufacturing processes and the high 
purity of chemicals used in an attempt to eliminate stray bacterial DNA makes it a very 
costly test to perform (~ $215 - 290 per test, compared to ~ $20 per test for automated 
blood cultures using the BACTEC or BacT/Alert). 
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Besides the high detection limits (that result in false negatives), contamination issues 
(that result in false positives) and high costs, there are a number of other fundamental 
problems that limit the potential use of PCR based systems. The first among these is the 
inability to detect uncommon pathogens (those not on the “included” list), that may 
result in gross failures in cases of emerging outbreaks of one such pathogen. The second 
is the questionable clinical validity of some of the positive results provided by PCR based 
techniques. The presence of bacterial DNA in the blood may be the footprint of the 
transient presence of bacteria not related to any infection (Bacteria may be temporarily 
introduced into the blood-stream by activities ranging from surgical draining of 
abscesses to brushing teeth), or it may be related to the persistence of circulating DNA 
still detectable several days after successful anti-infectious therapy has been completed. 
Questions also remain regarding the suitability of the PCR based techniques to the 
work-flow environment in a clinic or hospital. The requirement that reagents be not only 
sterile (free of live bacteria), but also free of bacterial DNA requires the use of 
automated robotic stations for extracting DNA and performing PCR / RT-PCR analysis. 
This would require much larger fixed costs (for equipment) and operating costs (for 
high-purity chemicals). It has been suggested that fixed costs (but not necessarily 
operating costs of supplies) can be reduced by 4 centralizing diagnostic facilities. 
Centralized facilities, however, have their own drawbacks, with time lost due to 
transportation and queues being primary concerns in this case, where time to diagnosis 
is of the essence.  
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There also exist modern, DNA based methods for reliably typing pathogens after pure 
cultures have been isolated, such as Pulsed Field Gel Electrophoresis (PFGE), Multi-locus 
Sequence Typing and spa typing. But these take 48-72 hrs, require dedicated facilities 
and trained labor, and are low throughput. They are thus unsuitable for routine clinical 
practice (though used on occasions for retrospective analysis of outbreaks) 
(Willemse-Erix and others 2009). Ideally, any new technology that seeks to reduce the 
diagnosis time (either just for detection of bacterial presence and its identification, or 
for the previous two plus antibiotic susceptibility profiling) must not only maintain the 
desirable features of the current “gold standard” technologies (automated blood culture 
for detection, biochemical tests for identification, and disc diffusion / broth dilution for 
antibiotic susceptibility testing) such as clinical relevance, broad applicability (low 
number of false negatives), and relatively low fixed and operating costs (of ~ 
$20,000-30,000 and ~ $30-50 per test, respectively), but it also must be amenable to the 
clinical workflow. Our proposed method seeks to achieve these very goals. 
 
1.2.4. SERS as a possible ultra-rapid alternative 
Raman signals arise from inelastic scattering of light incident on a sample. The 
wavelength shift (energy loss) of the scattered light is characteristic of the molecular 
vibrations at the surface. Since only one out of 1 million photons experience Raman 
Scattering, traditional Raman Spectroscopy works only for bulk samples or concentrated 
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solutions. In 1977, Jeanmaire and van-Duyne first demonstrated a huge (over 106 fold) 
enhancement of the Raman Scattering using a roughened noble-metal as substrate. 
However, it has only been recently that the mechanisms leading to the surface 
enhancement, (electromagnetic field enhancement at “nano”- sharp edge geometries 
and resulting charge transfer) have been properly understood (Schatz and Van-Duyne 
2002). Thus, Surface Enhanced Raman Spectroscopy (SERS) is a truly “nano” phenomena, 
occurring on the surface of nano-particles (Kneipp and others 2002) and on 
nano-textured surfaces (Moskovits 2005). When these “nano” surfaces are in contact 
with other molecules or materials (including cells), the scattered light conveys 
characteristics of the latter as well. Signal from a complex substrate (such as cell 
membranes) is complex, but by statistically comparing it to known signatures, one can 
make a good estimate about its identity.  
 
SERS is now an increasing popular analytical method. Precisely nano-patterned 
substrates, specially designed for SERS, are available commercially. The KlariteTM 
substrates are available on a 6mm*10mm chip (with a 4mm*4mm lithographically 
patterned functional region). Lin has used these substrates, along with a 785 nm laser 
excitation line with a 10s exposure time and 30mW laser power to detect and classify 
spores from five Bacillus strains (B. cereus ATCC 13061, B. cereus ATCC 10876, B. cereus 
sp., B. subtilis sp., and B. stearothermophilus sp.), and to identify various types of 
vegetative bacterial cells (Pseudomonas fragii, E. coli and Lactobacillus acidophilus) in 
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food substrates (Lin and He 2008). 
 
The main drawback of SERS at the moment is its requirement that the sample be “pure”. 
The proposed work will enable SERS to be applied to bacteria present in blood culture 
samples quickly (after < 1.5 hours of processing) as opposed to > 1 day taken by other 
researchers.  
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CHAPTER 2 
KINETICALLY LIMITED DENSITY DIFFERENTIAL CENTRIFUGATION 
2.1. Background 
Downstream microbiological procedures, such as the desire to perform Surface 
Enhanced Raman Spectroscopy (SERS) as in our case, may require the user to obtain 
“pure” bacterial samples. This means samples in which the bacteria are present at a 
fairly high concentration and contain very low amounts of contaminant species (other 
cells, organic and inorganic inerts etc.). Since the bacteria may be present in low 
concentrations within complex matrices (such as soil, food, stool and blood), isolating 
them from these matrices is always challenging. For instance, we desire to prepare “pure” 
isolates of the bacteria present in positive-flagged blood culture bottles for SERS. But 
while these bottles contain ~106 bacterial Colony Forming Units (CFU)/ml of suspension, 
they also contain ~108 RBCs/ml, a smaller number of other cells (WBCs and platelets), 
besides proteins and other macromolecules from the growth media.  
 
When designing the process to isolate (purify and concentrate) the target bacteria, one 
seeks to rely on properties that differentiate the target from other components of the 
matrix in which it resides. Because different matrices vary markedly in their composition, 
methods that work for one particular matrix may not work for another.  
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For instance, it is known that many bio-particles, including bacteria, have carboxyl and 
amino groups on their cell wall, which impart a net negative charge to them when the 
pH of the surrounding medium is high (>5.0). (Payne and Kroll 1991). Thus, at a high pH, 
they attach to positively charged surfaces, but will detach if the pH is lowered. This 
property of the bacteria has been leveraged to extract bacteria from soil samples using 
cationic ion exhange resins with an efficiency of about 35% (Jacobsen and Rasmussen 
1992). However, such a method is unlikely to work for blood since there are a large 
number of other cells, which are also likely to adsorb and desorb along with the 
bacteria.  
 
Another factor (besides selectivity of the target) that plays a major role in the choice of 
isolation protocol is throughput. An example of a very selective method that is not 
inherently high throughput is Dielectrophoresis (DEP), the motion of particles with an 
induced dipole in a non-uniform electric field. Their polorizability (ability to form 
induced dipole due to the presence of electric fields) can be used to isolate target 
bacteria. The DEP properties are very sensitive to cell physical and chemical properties, 
such as species, and has been used to separate different types of cells from each other. 
Herbbert and co-workers (Pohl 1978) tried to use an electrode to attract yeast in a 
solution, due to weak field gradients, the collection efficiency is quite low (only the yeast 
close to electrodes can be attracted). MEMS technology, which enables the fabrication 
of electrodes spaced just a few microns apart, allows the user to generate very high field 
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gradients (>106 V/m2) and to thereby increase the collection efficiency of target particles. 
The main drawback of DEP is that it cannot handle large sample volumes because the 
high field gradients do not penetrate very far (~10-100 microns) from the surfaces of the 
micro-electrodes. However, as we shall describe in the next chapter, they can still be 
used for certain low volume “polishing” steps. 
 
Centrifugation is perhaps the most common high-throughput method used to separate 
bacteria from their matrix in biology labs. Standard centrifugation is usually used to 
separate higher density bacterial particles from lower density matrices such as liquid 
growth media, milk, fruit juices etc. Differential centrifugation is a derived method based 
on difference in settling velocity of particles with different sizes and densities. In this 
method, the centrifugation speed is increased in steps. The particles with the highest 
density or largest size (which means highest settling velocity) will settle down fast and 
can then be removed from the sample. For instance, Neiderhasuer used centriguation at 
100 g first to eliminate large food particles, and then to collect bacteria using a 3000g 
centrifugation. (Niederhauser and others 1992)  
 
The drawback of differential centrifugation is that the centrifugation force required to 
pellet the larger particles (such as food debris or red blood cells in our project), is also 
sufficient to pellet smaller particles (such as bacteria, even though the settling velocity is 
less than larger particles). Consequently, contamination always exists in the 
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concentrated sample from the differential centrifugation method.  
 
Density gradient centrifugation is a common method in separation with high separation 
efficiency. During centrifugation process, particles in the sample will migrate to the 
portion of the tube at equilibrium density to form a band which can be removed for 
future experiment. Bakken (1985) used density gradient centrifugation to separate 
bacterial cells from soil. However, this method requires significant density difference 
between the target particle and other unwanted particles, and the procedure to prepare 
the density gradient solution is also quite complicated. Both drawbacks limit the 
application of this method. In our project, the density of bacteria like E coli is quite close 
to red blood cells, which also makes this method impractical for our project.  
 
Plate culture by itself can serve as a method to isolate bacteria from complex matrices. 
After some simple pretreatment methods such as centrifugation and dilution, the testing 
sample will spread on a growth-medium agar plate, and incubated (the growth medium 
may be selective or differential to a certain degree as well). The colonies formed provide 
a source of pure isolates of bacteria. In come cases the colony morphology itself can 
yield information regarding the identity of the bacteria. In most other cases, bacteria are 
collected from individual colonies and can be used for identification using traditional 
biochemical means, DNA based methods, or even by SERS. The main disadvantage of 
this method is, it needs a long time, usually 24 hours to get the results. But in many 
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cases, including ours (blood sepsis diagnosis), the need for quick results make the plate 
culture unacceptable (Kasai and others 2006; Mohd Adnan and Tan 2007; Balestrazzi and 
others 2009).  
 
2.2. Properties of experimental material 
Blood is a complex biological matrix which consists of plasma, red blood cells, white 
blood cells and platelets. The volume fraction of plasma to a human blood sample is 
about 55%. Plasma is mostly water. It also has some proteins and ions from other parts 
of human body. The density of plasma is quite close to water, around 1.025 g/ml.  The 
most common type of blood cells are the Red Blood Cells (RBCs), which are also called 
erythrocytes. The mature human RBC are flexible biconcave disks, with a diameter of 6-8 
um and thickness of 2 μm and a density of around 1.1 g/ml. The normal concentration of 
RBC in human body is about 4.6*109/ml (Sorette and others 1991). The second most 
important cell type present is the White Blood Cells (WBCs), also referred to as leukocyte, 
from the immune system. They are slightly lighter and larger than RBCs, with densities of 
1.06 to 1.08 g/ml and diameters of 10 to 12 μm. Their normal concentration is around 
4*106 to 1.1* 107/ml (Loos and others 1976). Platelets are comparatively smaller cells 
whose main function is to aid in the formation of blood clots. Their size is 2 to 3 μm in 
diameter, their density is about 1.05 - 1.07 g/ml, and the normal concentration is 
2.3*108/ml (Savage and others 1986). 
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Bacteria, on the other hand are smaller, denser particles. For instance, Escherichia coli  
(E coli) is a gram-negative bacteria rod that is typically 2 μm long and 0.5 μm in diameter 
with a density of around 1.105 g/ml (Martinez-Salas and others 1981; Baldwin and 
Kubitschek 1984). Other bacteria also have similar densities. The density of bacteria of 
clinical interest has been studied in the past (primarily using equilibrium density gradient 
centrifugation). Invariably, the values of density reported have been relatively high. Well 
documented values include 1.10 g/ml for E coli; 1.13g/ml for Streptococcus (Dicker and 
Higgins 1987), and 1.135 g/ml for Bacillus (Tamir and Gilvarg 1966).  
   
Filtered Tryptic Soy Broth (TSB) has a density approximately around 1.0 g/ml, that of 
plasma is 1.025 g/ml. So fluid in a suspension of 1 ml whole blood in 4 ml of TSB will 
have a density of 1. 005 g/ml. The density of the PBS solution is related to temperature 
and PBS concentration, for the room temperature (25oC) and 1X PBS, the density is 1.006 
g/ml (Schiel and Hage 2005). We worked with 2 kinds of mixtures: first, a mixture of 
sterile blood seeded with a known number of bacteria, and second, a mixture of blood, 
growth media, and bacteria that is similar to the contents of a blood-culture bottle by 
the time that it has been flagged as positive. Both of them have a fluid density between 
1.0 to 1.025 g/ml.  
 
Histopaque 1083, a commercial solution from Sigma Aldrich, is made up of polysucrose 
and sodium diatrizoate, and has its density adjusted to 1.083g/ml. This solution is 
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designed to be used to separate WBC and platelets from blood samples. However, in our 
project, we used it to help us to isolate bacteria, in addition to the WBCs and platelets 
from the RBCs (more details are presented in the following sections). 
 
All density properties are summarized in Table 2.1. 
 
Table 2.1 Summarized properties of experimental material 
 
 Name Density 
Fluid Blood plasma 1.025 g/ml 
TSB ~1.0 g/ml 
1X PBS 1.006 g/ml 
Histopaque 1083 1.083 g/ml 
Particles Red blood cells 1.1 g/ml 
White blood cells 1.06~1.08 g/ml 
Platelets 1.05~1.07 g/ml 
E coli 1.105 g/ml 
Streptococcus 1.13g/ml 
Bacillus 1.135 g/ml 
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2.3. Outline of the proposed technique 
The process proposed to isolate bacteria from all other components of the mixture 
(blood cells) is shown in Figure 2.1. The process is a modified version of density 
differential centrifugation to isolate the target bacteria. As with density differential 
centrifugation, we loaded the suspension containing the target particles on top of a 
higher density fluid. On centrifugation, only the particles with densities higher than that 
of the lower denser sediment went to the bottom of the tube, whereas, those with 
densities lower than the dense fluid remained on top (in the original suspension, near 
the interface between the two fluids). The key modifications were that we ensured that 
the depth of the second, dense fluid (the distance through which the particles sediment) 
is higher than a certain critical value, and the centrifugation time is deliberately limited 
to a specific calculated value. Making these modifications ensures that while all of the 
faster settling particles (RBCs, in our case) reach the bottom, all of the slower settling 
ones (bacteria, in our case) remain in the lower fluid, from which they can be isolated 
later.   
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Figure 2.1 Scheme of separation process 
(1): Mixture containing blood [consisting of RBCs (  ), WBCs ( ), platelets (  ) and bacteria (  )] 
are loaded on top of a fluid with a density less than that of RBCs and bacteria, but greater than that of 
WBCs and platelets. (2) Due to their density being lower than that of the lower solution, the WBCs and 
platelets are stopped at the interface. The RBCs and the bacteria continue the downward motion (the 
RBCs at a faster rate due to the larger size). (3) If the length of the lower fluid is long enough, then the 
RBCs that started at plane A overtake the bacteria that started at plane B, forming separate zones. (4) All 
the RBCs reach the bottom (form a pellet) while all of the bacteria are still in the lower solution. (5) If the 
process is allowed to proceed further, eventually all the bacteria reach the bottom (pellet) as well. 
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2.4. Experiment mathematical model  
As we mentioned in the experiment outline, only E coli and RBC have the density greater 
than Histopaque 1083, thus they can pass through Histopaque and settle down. 
However, since the size of bacteria like E coli are smaller than RBCs, their settling velocity 
is much slower (shown in section 2.5). So, if the liquid column of Histopaque is long 
enough, there will be a situation where RBCs starting at Plane A (Figure 2.1) outrun 
bacteria starting ahead at Plane B. If we limit the time the centrifugation process runs to 
just the time needed for all the RBCs to settle (point 4), just a pure solution of bacteria 
will be left behind.   
 
Based on the settling velocity of RBC and E coli in section 2.4, the required length of 
liquid column of Histopaque can be calculated. In order to get maximum E coli collecting 
efficiency, the time for the RBCs on Plane A to pass through both sample suspension and 
Histopaque 1083 need to be less than the time for E coli on Plane B to pass through 
Histopaque 1083. This can be expressed as 
  
   
 
  
   
 
  
   
                Equation 2.1 
Which also can be transformed to  
   
  
   
 
      
       
              Equation 2.2 
Where l2 is the length of Histopaque column, l1 is the length of sample column,     is 
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the velocity of RBC in sample column,     is the velocity of RBC in Histopaque,     is 
the velocity of E coli in Histopaque.  
 
However, since we just use the solution in the Histopaque liquid column for downstream 
analysis, the minimum length of the Histopaque column also needs to satisfy that, when 
the E coli on Plane B to settle to the bottom, the E coli on Plane A need settle in the 
Histopaque column. This case can be expressed as 
  
   
 
  
   
                   Equation 2.3 
Which is the same as 
   
  
   
                    Equation 2.4 
Where     is the velocity of E coli in sample column. 
 
From Equation 2.2 and 2.4, the length of Histopaque column    needs to satisfy two 
minimum requirements. Therefore, in our experiment, we will calculate both their 
values, then use the greater one to be the minimum constrain.  
 
The best time to collect E coli is when all RBCs settle down to the bottom, while most of 
E coli are left behind in Histopaque. In other words, the collection time is after settling 
down time of RBC, and before the settling down time of E coli. 
The settling down time of RBC is given by 
     
  
   
 
  
   
                 Equation 2.5 
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Similarly, the settling down time of E coli is 
       
  
   
 
  
   
                 Equation 2.6 
 
The number of E coli and RBC profiles in the Histopaque liquid (layer 2) are shown in 
Figure 2.2, the pink box is the appropriate time range for collecting E coli. The starting 
time is the settling time of RBC, and the stop time is the settling time of E coli. In that 
time range, we can collect most of the E coli and eliminate other unwanted bio-particles 
(RBCs, WBCs and platelets). 
 
Figure 2.2 Percentage changes of RBC and E coli in layer 2 at different times 
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2.5. Calculating sedimentation velocities in our system  
2.5.1. Sedimentation of individual particles 
 When a particle happens to be denser than the liquid in which it is suspended, it 
experiences a net force downward that is the difference between its weight and its 
buoyancy. For a spherical particle of density  and radius R suspended in a liquid of 
density l, this force is given by 
 
  
 
 
                        Equation 2.5 
 
   is the density difference between particle and surrounding medium. 
 
This force is counteracted by the viscous drag of the fluid. For a spherical particle moving 
though a continuous Newtonian fluid at low to moderate velocities (Reynolds Numbers < 
1) the drag force is given by the Stokes Equation (Equation 2.6) 
                          Equation 2.6 
where,   is the fluid's viscosity  
R is the radius of the spherical object  
 is the particle's velocity 
The particles settle (move downwards) with a velocity for which the two forces are 
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balanced. This velocity, obtained by equating equations 2.1 and 2.2 is thus given by  
                   Equation 2.7 
Stokes' law applies when the Reynolds number, Re, of the particle is less than 0.1. For 
the experiment in our project, the Re was less than 10-4. In our experiment, the 
centrifugation speed was 400g, viscosity of all the fluids are 0.001 kg/(m·s). 
 
The basic concept is applicable to particles of other shapes as well. But in these cases, 
Equation 2.3 needs to be modified, and an “effective radius” used for R.  The effective 
radius can be calculated analytically for certain geometries. For instance, for a prolate 
spheroid (a spheroid for which the polar axis is greater than the equatorial diameter, like 
American Football), the effective radius is given by  
                 Equation 2.8 
where, a is the major axis radius, b is the minor axis radius. On the other hand, for an 
oblate spheroid (an ellipsoid with a polar axis shorter than the equatorial diameter, like 
M&M candies), the effective radius is given by  
                 Equation 2.9 
In our case, we modeled “rod” shaped E coli bacteria as prolate speroids with a major 
axis of 1 μm, and a minor axis of 0.5 μm, and RBCs as oblate spheroids with a major axis 
of 3.5μm and a minor axis of 1μm. Consequently, supposing the centrifuge velocity is 
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400 rcf, we predicted sedimentation velocities of 2.67*10-5 m/s and 6.56*10-6 m/s for E 
coli though layer 1 (consisting of plasma and PBS) and layer 2 (high density Histopaque 
solution), respectively. The corresponding values for RBCs are 5.01*10-4 m/s and 
1.01*10-4 m/s.  
 
2.5.2. Hindered settling  
For a single spherical particle settling in an infinite fluid, we can use Stokes law to 
describe the behavior. If there are some interactions of particles in the fluid or the 
interactions of the particles with the container walls, the settling behavior will be 
modified (usually retarded). Settling that is significantly modified in such a manner 
known as hindered settling. A number of semi-analytic or empirical expressions are 
available to calculate effective settling velocities for systems with hindered settling. 
(Felice and Kehlenbeck 2000) 
 
One such correlation is the Richardson-Zaki Correlation, where the effective settling 
velocity is given by  
                   Equation 2.10 
where                        Equation 2.11 
 (  being the volume fraction number of all particles). For our project, in the first 
mixture (sterile blood seeded with a known number of bacteria, diluted by PBS as 1:1), 
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the volume fraction of red blood cells was about 0.25, given the volume fraction of RBC 
in whole blood was about 50%. In the second mixture of blood, growth media, and 
bacteria, the volume fraction of red blood cells was 0.1 (supposing the ratio of blood to 
growth media is 1:4). 
Therefore, when taking hindered effect into consideration, supposing the centrifuge 
velocity is 400 rcf, in the first mixture, the velocities of RBC though layer 1 (consisting of 
plasma and PBS) and layer 2 (high density Histopaque solution) are 1.30*10-4 m/s, 
2.62*10-5 m/s respectively. In the second mixture, the velocities are 3.07*10-4 m/s, 
6.18*10-5 m/s respectively.  
 
2.5.3. Cluster sedimentation 
In some cases, particles undergoing sedimentation may aggregate and form clusters 
during the process. As effectively larger “particles” are formed by the aggregation of 
smaller ones, the process of sedimentation speeds up. We observed such an effect 
(collection of aggregated particles) for RBCs in Histopaque 1083 (but importantly, not for 
E coli). Cluster sedimentation was studied by Allain. (Allain and others 1996) They 
assumed the cluster behaves as an impenetrable sphere with a hydrodynamic radius RH, 
and the velocity of the cluster can be expressed as 
                  Equation 2.12 
where a is the radius of the individual particle, s is the number of particles in an 
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aggregate, and will scale with R as s~( RH /a)
D, where D is the experiential number (from 
their experiment they find D is about 2.2). Therefore, the settling velocity of the cluster 
now becomes 
                  Equation 2.13 
where  means the settling velocity of the individual isolated particle. From our 
observations, there will be approximately 100 RBCs in each cluster, thus, taking into 
account both clustering and hindered settling, the settling velocities of RBC in the 
Histopaque layer are predicted to be around 1.39*10-4 m/s. 
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All the velocity calculating results are summarize in Table 2.2 (supposing centrifugation 
speed is 400 rcf) 
 
Table 2.2 Summarized calculating velocity results 
 
Particle  Solution In what condition Velocity Result 
E coli Sample suspension Normal 2.67*10-5 m/s  
Histopaque 1083 Normal 6.56*10-6 m/s 
RBC Sample suspension Normal 5.01*10-4 m/s 
Histopaque 1083 Normal 1.01*10-4 m/s 
Sample suspension Hindered effect 1.30*10-4 m/s 
Histopaque 1083 Hindered effect 2.62*10-5 m/s 
Histopaque 1083 Cluster 
sedimentation 
(s=100) 
1.39*10-4 m/s (D=2.1) 
1.89*10-4 m/s (D=2.3) 
2.56*10-4 m/s (D=2.5) 
3.47*10-4 m/s (D=2.9) 
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2.6. Experiment design and procedures 
Following the protocol for Histopaque 1083, the volume for suspension (blood sample) is 
3 ml, which will translate to a 3 cm length of liquid column in an Eppendorf centrifuge 
tube. The volume of Histopaque 1083 is the same, but the length will be slightly greater 
than 3 cm because of the cone end of the tube. From previous data, the lengths of both 
liquid columns meet the requirements as specified earlier in the section on modeling. 
 
Given 3 cm of both sthe ample and Histopaque column, from Equations 2.3 and 2.4, as 
well as velocity results in section 2.5, the time for all RBC to settle down is about 15 min, 
whereas for E coli is about 80 min. That is to say, when all RBC get settle down, most of E 
coli are still in Histopaque 1083 layer.  
 
Based on the mathematical model and calculations in previous sections, we conducted 
the following experiment to verify our method.  
The experiment procedure is listed as follows:  
1. Sample preparation.  
For the first mixture, the blood sample is sterile swine blood, and then seeded with 106 
CFU/ml E coli.  
The second mixture is blood culture. Sterile swine blood is diluted by TSB at a 1:4 ratio, 
then seeded with 102 CFU/ml E coli. The mixture is incubated for about 12 hours to let 
the E coli grow to 106 CFU/ml. 
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2. Centrifugation procedures. 
Following the protocol of Histopaque 1083, 3.0 ml Histopaque 1083 is added to the 
centrifuge tube, and then 3.0 ml blood mixture is carefully loaded onto the Histopaque 
1083 surface, then centrifuge at 400 rcf (400 g) for different times at room temperature. 
After centrifugation, the plasma/PBS suspension layer, Histopaque 1083 layer, and the 
RBC sedimentation layer are carefully transferred into different EP tubes, for future plate 
counting and RBC cell counting. 
 
 
Figure 2.3 Scheme of centrifugation experiment 
 
3. Counting procedures. 
Classic plate counting method is used for E coli counting. Each sample has 3 individual 
plates for counting the colony, and then the average number was taken for the final 
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results.  
For RBC, when the concentration is greater than 106 /ml, it was counted using 
hemocytometer. Otherwise, when the concentration is less than 106 /ml, the sample was 
first mixed with RBC lysis buffer, then the absorbance spectrum of lysis sample was 
measured. 
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2.7. Experiment data and discussion 
 
Figure 2.4 Observation and prediction concentrations of E coli /RBC in Histopaque 1083 layer at 
different time.  
The red squares are observation number of RBC in log scale, and the red line is the prediction 
number; the green squares are observation number of E coli, while green line is the prediction. Each 
observation data point is the average number of three individual experiments data.  
 
Both prediction concentrations of E coli and RBC were calculated using the following 
equation 
                Equation 2.14 
where  is the length of the Histopaque 1083 layer in the centrifuge tube. The 
0 20 40 60 80 100
5.5
6
6.5
7
7.5
8
8.5
9
Time/min
C
o
n
c
e
n
tr
a
ti
o
n
 o
f 
e
c
o
li
 &
 R
B
C
 i
n
 l
o
g
 s
c
a
le
36 
 
velocities of RBC and E coli are from section 2.5. 
 
For red blood cells, the ascending rate of observation is quite close to prediction, while 
the descending rate of observation is much less. That is because polysucrose, the 
ingredient of Histopaque, will aggregate red blood cells to form clusters, which will 
greatly increase the settling velocity, according to section 2.5. The RBC clusters usually 
consist od hundreds of cells, so as to increase the settling velocity by 20~100 times, 
compared to isolated individual cells. In that case, when blood cells pass through the 
interface of Histopaque 1083, most of them will form clusters and settle down in less 
than 2 minutes. 
 
For E coli, the concentration change of observation is quite similar to prediction, despite 
a bit different in the descending part. The reasons to cause such difference should be: a) 
the density of E coli in our experiment was not exactly 1.10 g/ml, some of them were 
slightly denser, which makes them move much faster in Histopaque 1083 than other E 
coli; b) there can be some errors in plate counting, which will affect the observation 
concentration; c) some E coli can aggregate together in solution, then slightly increase 
their settling velocity. 
 
Although there are some differences between observation and prediction, we can still 
see the significant distinction in settling velocities. As we predicted in Figure 2.2 and 
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Figure 2.3, after some minutes in centrifugation, almost all blood cells settled down 
while most of the E coli will keep in the Histopaque 1083 layer. From the experiment’s 
results, 40 to 60 minutes after starting will be the best time to isolate E coli. Since the 
density doesn’t vary too much in different bacteria species, we believe our method will 
also be applicable to other bacteria such as Streptococcus, Bacillus and so on.  
 
The bacteria enriched solution was used in following experiment, Flow Through 
Dielectrophoresis.  
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CHAPTER 3 
3. DIELECTROPHORESIS (DEP) 
3.1. Introduction to DEP 
Electric fields can induce the formation of dipoles even in particles that have no net 
charge. In a non-uniform electric field, a particle with such an induced dipole will 
experience a net force from the surrounding electric field. The migration of the particle 
caused by electric net force is termed as dielectrophoresis (DEP). The DEP force on an 
isotropic, homogeneous dielectric spherical particle is expressed as  
 
            
             
          (Equation 3.1) 
 
where    is the permittivity of free space,    is the relative permittivity of 
surrounding medium, r is radius of particle,     
  is root mean square electric field 
around the particle, and         is the real part of Clausius-Mossotti (CM) factor, 
which can be expressed as 
 
                      
  
    
 
  
     
   
                  
 
  
                  
         
  
 
  
          
         (Equation 3.2) 
where   
  and   
  are complex permittivity (  
    
  
 
        of particle and 
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medium, respectively (p and m are the respective conductivities). (Chen and others 
2007) 
It can also be seen that for high frequencies (w  infinity), the CM factor reduces to  
                   
       
         
              (Equation 3.3) 
 
whereas for low frequencies (w  0), it reduces to  
                        
       
         
              (Equation 3.4) 
 
Thus, at high frequencies, the CM factor is proportional to differences in the 
permittivities of the particle and the medium, whereas at low frequencies, it is 
proportional to differences in their conductivities. Further, it may be noted that the CM 
factor can be positive or negative. When it is positive, the DEP force is directed towards 
regions of high electric field strength, whereas when the CM factor is negative, the DEP 
force is directed towards regions of low electric field strength. Thus, a polizable particle 
can either move towards regions of high electric field strength (positive DEP or pDEP), or 
regions of low electric field strength (negative DEP or nDEP), depending on (a) the 
permittivity of the particle, (b) the conductivity of the particle, (c) the permittivity of the 
medium (d) the conductivity of the medium, and (e) the frequency of the applied field, if 
it happens to be alternating (AC).  
 
A salient feature of DEP is that the same particle can display p-DEP behavior at a 
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particular range of frequencies and n-DEP behavior over a different range. This typically 
happens if the conductivity of the particle is greater than the surrounding medium, but 
its dielectric constant (permittivity) is lower (or vice-versa). In such a scenario, the 
particle will display p-DEP at low frequencies, and n-DEP at high frequencies (the reverse 
being true for the vice-versa case), and there will also exist a critical frequency, called 
cross-over frequency (COF) given by   
 
      
                 
       
          
              (Equation 3.5) 
 
If different types of particles have different conductivities and/or permittivities, then 
they will have different COFs when dispersed in the same medium. Hence, at selected 
frequencies, (such as at a frequency higher than the COF of one particle, but lower than 
that of the other), one particle type may experience p-DEP, and the other n-DEP, thus 
providing a means of separating them. (Cheng and others 2007)  
 
3.2. DEP behavior of bio-particles  
Of special interest to us is the DEP behavior of biological particles such as bacteria of 
various species and blood cells of various types. Figure 3.1 shows the typical DEP 
behavior of biological cells when placed in a low conductivity buffer ( < ~ 100 μS/cm).  
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Figure 3.1 Scheme of dielectrophoretic spectra 
 
That we are able to observe DEP behavior in bio-particles implies that an effective dipole 
is formed within the particle, that is then pulled by net force in the non-uniform electric 
field. A number of sources contribute to determine the net effective polarizability of 
bio-particles. A very important one is the cell membrane, which, while made up 
primarily of a phospholipids bilayer, also harbor numerous protein and sugar molecules 
that serve as capacitative regions and produce charge distributions. Different species, 
which have characteristically different proteins and membrane composition, can hence 
be expected to show differences in DEP behavior. Also contributing to the effective 
polarizability is the cytoplasm, that contains molecules like DNA, RNA, proteins, etc. that 
are polarizable, but whose relative proportions may not vary as markedly among 
different species (Pohl 1978). 
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3.3. COF measurement of E coli, and Red Blood Cells 
 
We experimentally studied the DEP behavior of two bio-particles of particular interest to 
us: E coli (a representative bacterium) and Red Blood Cells (RBCs). Our experimental 
process is described below 
 
3.3.1. Quadruple electrodes 
As mentioned earlier, different bioparticles always have much different DEP effects in 
the same electric field. Before we use such difference in future experiments (like sorting), 
the exact DEP properties need to be measured. Generally, cross-over frequency (COF) 
will be used as the parameter to characterize the DEP behavior of a particular type of 
bio-particle. 
The quadruple electrodes were used in the COF experiment. Each set of electrodes 
consisted of four symmetric gold electrodes. The gap distance between electrodes was 
about 20μm and the thickness of gold layer was 100nm. They were fabricated using a 
process described in Section 4.4.   
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Figure 3.2 Quadruple electrodes 
(A) (Left) photo of quadruple electrodes. (B) (Right) Finite element simulation (using COMSOL) of 
electric field distribution produced by quadruple electrodes 
 
The AC signal from signal generator was applied to the electrode during the experiment. 
The left-top and right-bottom electrodes connected to the “live” port, while the rest two 
electrodes connected to the “neutral” port. After applying voltage, the high local electric 
field was generated between electrodes. From the finite element method result in 
Figure 3.2B, the regions between electrodes had the highest local intensity, and the 
symmetric center had the lowest (in the simulation, the dark blue dot in the center of 
the figure represents the lowest electric field intensity). Consequently, if the particle 
experiences positive DEP mobility, it will move to the region between the electrodes, 
and if it experiences negative DEP the particle will move toward the center.  
 
Since the solution in which the particles are suspended has a large effect on the 
behavior of the bio-particles, we must first sediment out the particle from whichever 
solution it happens to be in (plasma, growth media etc) and resuspend in our buffer of 
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choice (e.g. 1X manitol + saline + amino-hexanoic acid (AHA)) This “centrifugation and 
resuspension step” may need to be repeated 2 to 3 times to ensure that the properties 
of the suspending solution are as desired. Electrodes are connected to the signal 
generator while the output is kept in the off state. The output voltage is set to 6 Vp-p, 
and the initial frequency to 100 kHz. The motion of particles will be recorded (usually be 
positive-DEP at this frequency, which means move toward the gap between electrodes). 
The frequency is tuned higher step wisely until the particles suffer negative-DEP, which 
means move toward center. The frequency when particles turn to be negative-DEP is the 
cross-over frequency. Procedure 4 requires repeating several times until a stable result is 
accomplished. 
  
Figure 3.3 Photos of particles with different DEP properties 
A, photo of particles that have positive DEP;  
B, photo of particles that have negative DEP 
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3.3.2. COF measurement result (E coli and RBC in different solutions) 
There are practical limitations on the frequency range that we can test, and on the 
frequencies that can be used when carrying out the sorting in future. The available 
signal generator can only produce a signal with frequency up to 120 MHz.  Also, at low 
frequencies (< 100 KHz) bubbles are generated due to electrolysis. Hence, it would be 
ideal if the cross-over frequencies for different cell types were not only distinct, but also 
were within this range (100 KHz to 120 MHz). One way to achieve these goals is to 
modulate the conductivity and permittivity of the solution that the particles are 
suspended in. As seen in Equation 3.5, changing the solution conductivity ( m) and 
permittivity ( m) will change the COF of the particle. Our basic solution is an isotonic 
solution of Mannitol. Mannitol is a sugar-alcohol that most bacteria are not able to 
metabolize. Hence, the bacteria remain in a static (non-growth) phase during the time 
they are suspended in the solution. Mannitol also happens to not affect the conductivity 
or the permittivity of the solution in a measurable manner. We adjusted the conductivity 
of the solution by adding known amounts of saline (NaCl solution) and the permittivity 
by adding known amounts of Amino-Hexanoic Acid (AHA). AHA is a qwitterionic 
molecule that has both positive and negative charged groups, and hence contributes 
significantly to the permittivity of the solution, while only weakly affecting the 
conductivity. As reported in Table 3.1, a solution consisting of a mixture of Mannitol, 
saline (NaCl) and AHA was found to ensure that the COF of the bacteria and RBCs were 
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as desired.  
 
The COF of E coli and RBC in different DEP solutions are summarized in the Table 3.1. 
 
Table 3.1 COF of Red blood cells in mannitol mixture 
 
Basic solution 1X mannitol No NaCl 0.02% NaCl 
No AHA All + in 100kHz~120MHz  
0.4M AHA 23 MHz from + to -, weak 
mobility in (20~28 MHz) 
30 MHz from + to -, weak 
mobility in (20~30 MHz) 
1M AHA 8 MHz from + to -, weak 
mobility in (5~20 MHz) 
10 MHz from + to -, weak 
mobility in (5~15 MHz) 
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Table 3.2 COF of E coli in Mannitol mixture 
 
Basic solution 1X mannitol No NaCl 0.02% NaCl 
No AHA All + in 100kHz~120MHz  
0.4M AHA 60 MHz from + to -, weak 
mobility in (20~100 MHz) 
75 MHz from + to -, weak 
mobility in (30~90 MHz) 
1M AHA 22 MHz from + to -, weak 
mobility in (20~80 MHz) 
60 MHz from + to -, weak 
mobility in (50~75 MHz) 
 
In order to utilize the DEP difference to isolate E coli from bacteria, we used a solution 
that could provide a significant difference between target particles. As shown in Table 
3.1 and 3.2, 1X mannitol + 1M AHA + 0.02% NaCl was the choice. The principle to 
separate E coli or other bacteria from blood cells using our device was discussed in the 
next chapter.  
 
3.3.3. Measurement of dielectrophoretic mobility 
A more rigorous way to examine the DEP behavior of bioparticles is to obtain the 
dielectrophoretic mobility of the bio-particle at various frequencies. The DEP force that a 
particle suspended in solution experiences is balanced by the drag on the particle, and 
the particle moves with a constant velocity. 
 
48 
 
From the previous chapter, the stokes drag force for sphere particle is        , 
which will balance the force from DEP shown in Equation 3.1. In this case,   
              
             
 . Consequently, we get  
     
  
 
  
               
            (Equation 3.6) 
r, radius of the particle;  , viscosity, 
The definition equation of DEP mobility is given by 
 
      μ         
               (Equation 3.7) 
Where      is the velocity; μ    is DEP mobility 
 
     
  is the gradient of     
 , which can be expressed as 
     
      
    
         
   
  
      
   
  
      
   
  
      
   
  
    
(Equation 3.8) 
 
For a spherical particle,  
μ     
  
 
  
                         (Equation 3.9) 
 
       , real part of the Clausius-Mossotti factor 
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3.3.4. Mobility calculation procedures 
 
 
Figure 3.4 Some frames of moving pseudomonas used in mobility calculation. 
 
1. The video of moving target particles is recorded (by Q-Capture) when particles suffer 
either p-DEP or n-DEP force. Then it is opened in Image J to generate several frames 
showing the moving process of particles.  
2. The center of quadruple electrodes is located will be set as the origin point of 
coordinate axes. The proper particle is selected which has clear motion and the direction 
doesn’t change too much during the whole moving process, shown in the red circle in 
Figure3.4. Then get the normalized coordinates of the particles mass center in each 
frame, given that the distance of gap between electrodes is 20μm. For example, the 
normalized coordinates of a particle in Figure 3.4A are [11.2 2.8]; in Figure 3.4B are [10.1 
1.0] (Unit is μm). 
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3. Given the time interval between each frame in the video is 0.328 sec, and the 
normalized coordinates of the particle in each frame, the average velocity can be 
calculated between those frames. The average velocity from Figure 3.4A to Figure 3.4B is: 
[-3.35 -5.49] ((x2-x1)/0.328, (y2-y1)/0.328, unit is μm /s); 
4. According to Equation 3.7, the mobility is velocity divided by      
 . In order to get 
more accurate result, the      
  calculated in the center point of the moving process 
will be used in calculation. The gradient result can be calculated in COMSOL using 
Equation 3.8.  
For instance, the center point from Figure 3.4A to Figure 3.4B is [10.65 1.9]; 
From COMSOL, the value of      
  at [10.65 1.9] is [3.10e15 1.03e15] (unit is V2/m3) 
According to Equation 3.3, μ     
    
   
  
      
     
, so μ    is -1.97*10
-21 (unit is 
V2/m4) 
5. Procedures 1 to 4 will be repeated for each frame, as well as for each video (usually 
have some different videos for the same particle), to get average mobility for the particle. 
For instance, according to our calculation, the average mobility of pseudomonas in 1MHz 
is -2.10*10-21 V2/m4 
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CHAPTER 4 
4. MEMS DEVICE DESIGN AND FABRICATION 
4.1. DEP behavior of bio-particles in device 
The Purpose of our device is to be able to sort particles at high throughput (> 100 
particles/sec). The combination of laminar fluid flow and DEP will help us to realize our 
goal. As shown in Figure 4.1A, when the electric field is absent, all particles in fluid flow 
will keep the same direction of motion, which is the same as the streamline of fluid flow 
(supposing the flow is laminar, which will be discussed more in section 4.3).  
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Figure 4.1 Scheme of bio-particles behavior in device.  
The purple dot is positive-DEP bio-particle and blue dot is negative-DEP bio-particle. 
 
As shown in Figure 4.1B, a particle experiencing p-DEP (purple dot) will suffer a DEP  
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force (red arrow) directed towards regions of the high electric field (the gap space 
between the parallel electrodes in this figure). At the same time, moving fluid will also 
apply a force (light blue arrow) on the particle. Finally, if we ignore the gravity (usually 
very small for bio-particles in solution), the direction of the composition force (green 
arrow) will be toward the electrodes. The combined effect of the two forces causes the 
particle to be drawn into the region between the electrodes and remain at, or very near, 
its original streamline. On the other hand, if the particle experiences n-DEP (blue dot), 
the DEP force will act in the opposite direction, trying to repel the particle from the 
region between the electrodes. The fluid force, however, continues to act in the same 
direction. Therefore, the direction of the effective force will be parallel to electrodes. 
The n-DEP bio-particles will traverse a path parallel to the electrodes, and once the 
electrode ends, will begin flowing along the local streamline of the fluid.  
 
4.2. Device design 
In order to validate the core sorting technology that works based on a combination of AC 
electric fields and laminar microfluidic flow, we fabricated and tested an integrated 
microfluidic chip to separate target bio-particles (bacteria and RBC). Bio-particles suffer 
the DEP force from the electric field generated by electrodes in the device, and then 
have different moving behaviors, either attracted or repelled by electrodes, based on 
their different DEP properties. This device is very similar to that used by Cheng and 
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others (2007).  
4.2.1. Outline of 1st generation device function 
This first generation integrated chip, shown in Figure 4.2, involves four different stages: 
trapping, focusing, sorting, and collecting. 
 
 
Figure 4.2 Photo of the 1st generation device (Cheng and others 2007) 
 
The first parallel planar electrode array from the inlet (the left-most part of Figure 4.2) is 
called the trap. The design of the trap is such that it captures all particles that suffer 
positive DEP while allowing those that suffer from negative DEP to pass through. This 
trap is operated at a low frequency, and unwanted debris which displays positive DEP 
can be trapped by this structure. As will be explained in the next section (future work), 
this selectivity can, and if needed, be employed to enhance the capabilities of the 2nd 
generation sorter. 
 
The second stage of the device is the “focusing unit.”  It has two parts, which have 
different types of planar electrodes. Both these electrodes are operated at a relatively 
high frequency. At this frequency, all the particles (RBC and Bacteria) suffer negative DEP, 
55 
 
and are repelled by electrodes then hence directed toward the center of the channel. 
The first pair is a coarser focusing unit, bringing the particles from the entire 1mm 
channel to a width of 50 μm, while the second set of electrodes (the interdigitated ones) 
are used for a finer focusing process, bringing the particles to a region of 20 μm and 
forming a single line of particles. Bringing all the particles into single file along the center 
of the channel ensures that when they reach the sorter downstream, all the particles 
will experience the same fluid flow field and electric field, and hence their behavior in 
the sorter will be determined solely by the dielectrophoretic properties of the particles. 
 
 
 
Figure 4.3 Scheme of sorting part 
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The third part of the chip is the sorting unit. In the current design, this unit has three 
“3D” electrodes (aligned pairs of electrodes along the top and bottom of the channel). 
These electrodes are operated at progressively higher frequency. Supposing we have 
three different kinds of particles to isolate, whose COF frequencies are  1,  2,  3, 
respectively. In our project, those three particles will be RBC, E coli and unwanted 
particle in blood sample. At the first electrode (that operates at  4, which is greater than 
all the COF of three particles), all three particle types suffer negative DEP and are 
repelled by the electrodes. In conjunction with the fluid flow field, they traverse a path 
parallel to the electrodes and are guided to one end of the channel. Here they encounter 
another 3D electrode gate, –but this one operates at a slightly higher frequency  5. At 
this frequency, one of the particle types suffers positive DEP and is hence dragged 
toward and through the electrode ‘gate”, following which it traverses a path along the 
fluid streamline close to the channel wall and exits through the bottom outlet. The two 
other particles behave like before and are guided to the other extreme of the channel, 
where they encounter the third electrode, which operates at a frequency higher than 
that of the crossover frequency of one of the two remaining particle types. As shown in 
Figure 4.3, particles of this type are guided to exit from the bottom outlet, whereas the 
remaining particle type (that suffering negative DEP throughout) is once again repelled 
and guided out through the central outlet.   
 
The fourth and final stage of the integrated chip is collecting and concentrating the 
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bacteria after they have been sorted. Due to the high aspect ratio (ratio of width to 
height) of the channel, the resulting flow profile (commonly referred to as the 
Hele-Shaw profile) is not parabolic, but exhibits a small boundary layer, whose thickness 
is roughly equal to the channel height near the side wall where the flow velocity is very 
small. Therefore, at the sides the particles will suffer the least viscous drag and be 
influenced most by DEP forces. The 3-D DEP trap electrode has been designed based on 
this principle. The angling is highest within the boundary layer and quickly curved 
towards an angled sharp tip. The focusing action of the highly inclined gate at the side 
and the high field at the tip allows rapid concentration of bacteria to the tip of the trap. 
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4.2.2. Proposed 2nd generation system 
 
 
Figure 4.4 Scheme of proposed 2nd generation system 
 
A preliminary design of the proposed microfluidic chip is shown in Figure 4.4. As seen, it 
essentially consists of the 4 sorter units described in the previous section laid out in 
series with refocusing units between them. As described in the previous section (and 
also shown in the inset of Figure 4.4), in each individual sorter unit, the bio-particles 
with a crossover frequency (COF) lower than that of the second electrode are steered 
towards the lower outlet; those with a higher COF, but lower than COF of the third 
electrode are steered into the upper outlet, and particles with the highest COFs exit 
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through the center. In the proposed design, these particles are fed to the next stage, 
where the bacterial types with progressively higher crossover frequencies are siphoned 
away to the top and bottom exits. As with the first generation device, the bacteria 
steered to the side-channel exits will be collected using a crescent-shaped 
dielectrophoretic collector operating at a frequency just below that of the electrode 
guiding the bio-particles into that particular channel. 
 
Since only those particles that display positive dielectrophoresis (pDEP) are steered to 
the side-channels (marked 1 through 8), particles, such as the non-cellular debris, that 
are expected to show negative DEP throughout the applied frequency range will pass 
straight through the device, through exit 9, and subsequently discarded. No particles 
should be collected at the collection (crescent shaped) electrode at this exit.  
 
Not pictured in the figure is the trap located upstream of the first set of gate electrodes. 
This trap, as explained in the previous section, captures particles that suffer positive DEP 
at its operating frequency. If it is desired that the bacterial population should be sorted 
into more than 8 groups (based on dielectrophoretic mobility), then the trap can be used 
to collect a large fraction of the bacteria first and then progressively release some 
particles by gradually changing the applied frequency. For instance, if the trap is 
operated at a frequency of 10 MHz, only those bacteria with a COF above 10 MHz will 
pass through to the sorter properly. The gates can then be operated at varying 
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frequecies from 12 to 24MHz, thus releasing the respective bacteria with COF in those 
ranges of interest. After that, clear running buffer can be pumped through the system, 
and the operating frequency of the trap switched to 1 MHz. Now all the bacteria 
(bio-particles) with COFs between 1 and 10 MHz will be released for sorting and 
quantification. We believe that the “trap + 4-stage” (8 bio-particle bin) design represents 
an achievable balance between two demands: turnaround time for the sample and 
complexity of the device. Alternatively, one can link several of the 4-stage chips depicted 
in Figure 4.4 in parallel and in series to achieve massively parallel sorting into 20 bins or 
more. The chips can be linked in a modular fashion and be connected by tubing. The 
operating frequencies of the sorting gates on each module will, however, vary from chip 
to chip in order to achieve finer sorting into more bins.  
 
In contrast, a trap and single stage sorter is comparatively easy to design, fabricate and 
operate. In theory, such a device can be used to sort and quantify bio-particles over a 
broad range of COFs. The major limitation, however, is that one would have to tolerate 
long turn-around times as the particles with different COF ranges are sorted and 
collected one after the other, in series, with respect to time. Putting more stages makes 
the device overly complicated, especially with respect to balancing fluid flow, and more 
prone to malfunction (the greater the number of independently operating parts, the 
greater the chance that at least one of them will malfunction). The 4-stage device 
proposed in this study is a reasonable size that can eventually be modified into a 
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hand-held device. 
 
4.3. Design of 4-stage system 
A few design issues need to be worked out for the 4-stage sorter. The primary one is to 
ensure that the fluid flow is not biased towards any of the 9 outlets of the system. This 
can be ensured by adjusting the dimensions (width and length) of the channel to insure 
that the total resistance to fluid flow through each of the side channel is the same. 
Qualitatively, this results in a design where the outlets from the latter stages are run 
through progressively shorter lengths before the bacteria are trapped and/or the fluid is 
allowed to drain away. 
 
4.3.1. Laminar flow 
Laminar flow, also called streamline flow, occurs when the fluid flows in parallel layers 
and there is no intermixing between layers.  
Reynolds number is the parameter of fluid flow which will always be used to describe 
flow status. It is given by 
   
   
 
                  (Equation 4.1) 
where   is the density of fluid,   is average velocity in cross section, D is the 
hydrodynamic diameter of channel,   is viscosity of fluid (Bird and others 2004). 
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If the dimensionless Reynolds number of the fluid is less than 2300, it will be considered 
as laminar flow. Fortunately, because of the extremely small dimension of the MEMS 
device channel, as well as the flow velocity, the Reynolds number is always much less 
than 2300, which means the fluid flow in our device is laminar. For example, the flow 
rate in our device is ~1ul/s, and the cross section is 1.5 mm*50 μm. Supposing the fluid 
is water, then the Reynolds number in this case will be 13, which is much less than 2300, 
thus we can say the fluid flow in our device is laminar.  
 
4.3.2. Pressure drop equations 
For pressure driven flow in our device, the equation of pressure drop is  
     
   
      
 
  
  
  
             (Equation 4.2) 
Where    is the pressure drop through the channel, g is gravity,      is the effective 
hydrodynamic diameter of channel cross section,    is the real hydro diameter of 
channel cross section, L is the length of channel.  
 
The velocity can be expressed as 
  
 
 
 
 
  
                 (Equation 4.3) 
where Q is the flow-rate, A is the area of cross section, W and H are the width and 
height of channel, respectively.  
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The effective and real hydro diameter of channel cross section are given by 
     
  
 
   
  
 
  
  
             (Equation 4.4) 
Where f is the fraction factor,    is the perimeter of cross section, which is 2*(W+H) in 
our device.  
 
The friction factor is related to width/height ratio of cross section, roughly it can be 
expressed as a function of width and height,  
          
 
 
          
 
 
          
 
 
          (Equation 4.5) 
From above equations, we can get 
   
        
      
                 (Equation 4.6) 
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4.3.3. Equivalent circuit 
 
The fluid flow in the system is analogous to the flow of the electric current within an 
electrical circuit.  The pressure drop (P) over a section is analogous to the voltage 
drop over a resistor in electric circuit, the flowrate (Q) is analogous to the current, and 
the proportionality factor (the rest of equation) is analogous to the resistance. The 
equivalent circuit is shown in Figure 4.6. 
 
Figure 4.5 Scheme of the pressure drop relationship 
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Figure 4.6 scheme of equivalent circuit 
 
In order to get the balanced flow in each outlet, which means i1=i2…=i9, we will adjust 
the resistance of each channel part.  
 
For the sake of making the calculation be easier, the R10, R11 and R12 are set to equal.  
                            (Equation 4.7) 
 
It’s easy to find out such relationships if the currents are balanced 
                           (Equation 4.8) 
 
Applying circuit theory, we obtained the following constraints on the “resitors” in order 
to have all the currents labeled i1 to i9 to be equal to each other. 
For example, i5*R5=i6*R6=(i7+i8+i9)*R12+i7*R7+i8*R8+i9*R9 
Thus, the constraint is 
                            (Equation 4.9) 
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More constraints can be gotten from similar calculations, 
                           (Equation 4.10) 
                           (Equation 4.11) 
 
 
In fluidic terms, the “resistance” of a particular section of the channel is a function of its 
length, width, and height, and these parameters need to be adjusted to obtain 
resitances that conform to the constraints above. Since all the sections will be fabricated 
on the same substrate using Liquid Phase Photopolymerization (Sengupta and others 
2002), all the sections will have the same height. The choice of height will be determined 
in part by the throughput we desire to handle, with larger heights being used for higher 
volume throughput devices.  
 
Once the height is specified, the other variables are the widths and lengths of individual 
sections. As seen in Equation 4.6, the resistance happens to scale linearly with respect to 
length, but in a more complex manner with respect to width. So, from a calculation point 
of view, it is easier to specify widths of individual sections (with the widths of the 
daughter channels smaller than that of the mother channels), and calculate the desired 
lengths for each segment. Values of the width are chosen in a manner than the 
corresponding lengths obtained are “reasonable” (the system can fit within a larger 6 
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inch x 8 inch cassette. This is done for one height (100 microns).  
 
The lengths of the channel also determine the location of the electrodes (for the trap, 
the aligners, the sorter gates and the collectors) and fluidic outlets. We would prefer to 
be able to use the same set of top and bottom plates to also fabricate channels with 
different heights. In this case, the lengths are obtained from the previous result, and the 
widths are calculated to ensure balanced flow.  
 
The trap is a grid, and the aligners are located along the center of the channel. Similarly, 
the collector collects particles from all regions of the channel and brings them to the 
center. Hence, they will work as long as the channel is narrower than a certain value. For 
the sorting gate electrodes to work, they need to convey the particles to a range of 
streamlines that exit through a desired gate. They are designed such that they either 
bring the particles to the exact center, or they direct them just barely into the side 
channels for the the widest channels (that also happen to be the ones with the greatest 
height). This ensures that they do not span all the way across (and act like a collector) for 
the narrower channels.  
 
In a specific height circumstance (such as 100μm), we should design the width of each 
part, and calculate the length, since the relationship between resistance and channel 
length (linear relation) is much simpler than the relationship between resistance and 
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channel width.  
 
Another problem we need figure out is, from the above paragraph, we can get the 
channel length of each part by giving the width, in a specific channel height (for example, 
100μm). However, the devices with different heights (such as 25μm, 50μm, 200μm etc) 
are always needed for research. Then, the 100μm -height device will be used as a 
template device, to design other similar devices which have different channel heights. 
We keep the length of each part, and change the width to make the fluid flow in each 
outlet to be equal. Consequently, we will get a high order equation of width to solve.  
 
4.3.4. Calculation results 
A Matlab program is designed for calculation, which will be attached in the appendix of 
the thesis.  
The calculation results are shown in Table 4.1 and 4.2.   
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Table 4.1 Calculation results of width of each channel 
 
 
 
Table 4.2 Calculation results of length of each channel 
 
 
70 
 
 
Figure 4.7 CAD channel design of the 2nd generation device, 100μm height. 
 
 
4.4. Fabrication procedure 
4.4.1. Electrodes fabrication 
A two-step process is used to fabricate our DEP chip. First, the electrodes were 
fabricated in Dr. Shubhra Gangopadhyay’s lab using photolithography and lift-off on 
standard 3” x 1” glass slides. The method is summarized in Figure 4.8. We fabricated two 
designs, one with electrodes that will be located on the upper surface of the chip, and 
one with electrodes that will be located on the lower surface of the chip. An 
upper-lower pair was aligned using an optical microscope, and the channels fabricated 
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using liquid phase photopolymerization (process outlined schematically in Figure 4.9).   
 
 
Figure 4.8 Process of electrodes fabrication 
Glass Slide
Photoresist
Preparing Glass Slides
•Soak in piranha solution (75% HCl, 
25% H2O2)
•Wash with soap and water
•Rinse with acetone, methanol, 
then isopropynol
Photoresist:
•Spin adhesion promoter onto 
surface
•Spin negative photoresist (AZ 2020) 
onto surface 
•Soft bake at 115 degrees for 60 
sec
UV exposure
•Expose slide to UV light for 4 
seconds (time depends on 
photoresist used)
•Hard bake for another 120 sec
•Develop slides in developer 
solution (MF 300)
Metal Application
•First layer-titanium
•Second layer-gold
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4.4.2. Chip fabrication.  
 
Figure 4.9 Process of electrodes fabrication 
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4.4.3. Obstacles in 2nd generation chip fabrication 
We already made some 1st generation devices; however, the attempt to fabricate the 2nd 
generation failed. Since the width of the side channels are quite small, it’s really hard to 
wash the unpolymerized channel with acetone, as well as make the accurate width of 
each channel. In the future the 2nd generation chip may be fabricated using SU-8 or 
PDMS, which have better mechanical properties, more suitable for the fabrication of fine 
channels.  
 
 
  
74 
 
CHAPTER 5 
FUTURE WORK 
 
The future work includes three major aims: 
1. Using the 1st generation device to isolate bacteria from the coarse purified solution by 
Kinetically Limited Density Deference Centrifugation. Further research like isolation 
efficiency and bacteria survival rate will be studied in this step. 
2. Identification of bacteria isolated by our device using Surface Enhanced Raman 
Spectroscopy (SERS will be tested). 
3. Fabrication and testing of a 2nd generation device by SU-8 or other polymerizable 
material with better mechanical properties. 
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APPENDIX 
Matlab program of section 4.3 
 
function RPL=f1(w,h);% define R=RPL*ul 
x=h./w; 
y = -50.416.*x^3+ 132.75.*x^2 - 121.22.*x + 95.705; 
RPL=y.*(w+h)^2./(8.*(w.*h)^3); 
 
function R=f2(r7,r10)  %given r7 and r12, we can use this function to calculate the 
other r 
r9=r7; r8=r7; 
r11=r10; r12=r10; 
r1=15.*r10+r7;r2=r1; 
r4=8.*r10+r7; r3=r4; 
r5=3.*r10+r7; r6=r5; 
R=[r1,r2,r3,r4,r5,r6,r7,r8,r9,r10,r11,r12]; 
 
W=input('Please enter w1 to w12');  
h=input('Please enter channel height');  
l7=input('Please enter channel 7 length'); 
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l10=input('Please enter channel 10 length'); 
r7=f1(W(7),h).*l7;%calculate the resistance of part 7 
r10=f1(W(10),h).*l10;%calculate the resistance of part 10 
R=f2(r7,r10);%calculate the resistance of other parts 
for (i=1:12) 
FPL(i)=f1(W(i),h); 
    L(i)=R(i)./FPL(i); 
end 
 
w2=zeros(1,12); 
a1=-50.416; a2=132.75; a3=-121.22; a4=95.7057;h2=0.025;h=0.1; %the height of this 
program is 25μm, but we can change the height h2 and constant to get the real solution 
of the high ordered equation 
RPL2=RPL./(0.004*h/h2);  %0.004 is the constant multiplied with RPL 
for (j=1:12) 
 
p=[a1.*h2^2/8, a2.*h2/8+a1.*h2/4, a3/8+a2/4+a1/8, a4./(8*h2)+a3./(4*h2)+a2./(8*h2), 
a4./(4*h2^2)+a3./(8*h2^2), a4./(8*h2^3), -1*RPL2(j)]; 
r=roots(p); 
r2=r';r3=1./r2; 
for (k=1:length(r2)) 
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    if abs(1./r2(k)-W(j))<0.5*W(j) 
        w2(j)=1./r2(k); 
    end 
end 
end 
 
for (i=1:12) 
RPL2(i)=f1(w2(i),h2); 
    R2(i)=L(i).*RPL(i); 
end 
 
t1=R2(10)*15+R2(7); t2=R2(10)*8+R2(7);t3=R2(10)*3+R2(7); 
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